#bundibugyo — Public Fediverse posts

https://www.europesays.com/afrika/51028/ Ebola in der Demokratischen Republik Kongo: Rekord-Todeszahlen und steigende Fälle #AI #ArtificialIntelligence #Ausbruch #Bundibugyo #DRKongo #Ebola #Epidemie #Fälle #Ituri #kampala #KI #Kontaktverfolgung #KünstlicheIntelligenz #RepublicOfTheCongo #RepublikKongo #Todesfälle #Uganda

2nd meeting of #IHR EC on #epidemic of #Ebola #Bundibugyo virus disease in #DRC – Meeting report (WHO, August 29 '26), https://etidiohnew.blogspot.com/2026/08/2nd-meeting-of-ihr-ec-on-epidemic-of_01947028083.html

2nd #meeting of #IHR EC on #epidemic of #Ebola #Bundibugyo virus disease in #DRC – Meeting report, https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report

Operational #epidemiology of the early phase of the 2026 #Bundibugyo virus disease #outbreak in the #DRC and #Uganda, https://etidiohnew.blogspot.com/2026/08/operational-epidemiology-of-early-phase.html

The family of the #Ebola patient—including his children—faced a high risk of infection. With Ebola often deadly in young children, the #CharitéBerlin team decided to use a preventive treatment for the first time. In our second Paper spotlight, the researchers share what they learned:

👉 https://www.charite.de/en/research/paper_spotlight/new_findings_on_preventive_treatment_after_exposure_to_bundibugyo_ebola_virus/

#CharitéPaper #Bundibugyo #MBP134 #medicine #science #research #ScienceMastodon

Die Familie des #Ebola-Patienten – inklusive seiner Kinder – hatte ein hohes Risiko, ebenfalls an Ebola zu erkranken. Aufgrund der hohen Sterblichkeit insbesondere für Kleinkinder entschied sich das behandelnde #CharitéBerlin-Team, ein Medikament erstmals vorbeugend einzusetzen. Die Erkenntnisse in unserem zweiten Paper spotlight:

👉 https://www.charite.de/forschung/paper_spotlight/neue_erkenntnisse_zur_vorbeugenden_behandlung_nach_kontakt_mit_dem_bundibugyo_ebolavirus/

#CharitéPaper #Bundibugyo #MBP134 #Medizin #Wissenschaft #Forschung #ScienceMastodon

In June we discharged the U.S. #Ebola patient fully recovered. Now #CharitéBerlin researchers share findings from his experimental treatment. Learn about symptoms, viral loads, and immune responses in our Paper spotlight:

👉 https://www.charite.de/en/research/paper_spotlight/new_findings_on_treating_a_bundibugyo_ebola_virus_infection/

#CharitéPaper #Bundibugyo #MBP134 #remdesivir #medicine #science #research #ScienceMastodon

Im Juni konnten wir den US-amerikanischen #Ebola-Patienten genesen entlassen. Jetzt haben #CharitéBerlin-Forschende seine experimentelle Behandlung wissenschaftlich aufgearbeitet. Mehr über Symptome, Viruslasten & Immunantworten in unserem Paper spotlight:

👉 https://www.charite.de/forschung/paper_spotlight/neue_erkenntnisse_zur_behandlung_einer_bundibugyo_ebolavirus_infektion/

#CharitéPaper #Bundibugyo #MBP134 #Remdesivir #Medizin #Wissenschaft #Forschung #ScienceMastodon

Can a vaccine built for one Ebola virus stop another? The World Health Organization is about to find out
#Health #Ebola #Bundibugyo #EbolaVirus #EbolaOutbreak #Ervebo #WHO #DRC #DemocraticRepublicOfTheCongo #PublicHealth #Vaccines #GlobalHealth #Africa
https://the-14.com/can-a-vaccine-built-for-one-ebola-virus-stop-another-the-world-health-organization-is-about-to-find-out/

A #review of #Bundibugyo virus and the 2026 #outbreak: lessons for #epidemic #preparedness, https://etidiohnew.blogspot.com/2026/08/a-review-of-bundibugyo-virus-and-2026.html

#Bundibugyo #ebolavirus from the 2026 Ebola #outbreak in #Uganda and #DRC: a new #variant, https://etidiohnew.blogspot.com/2026/07/bundibugyo-ebolavirus-from-2026-ebola.html

#Bundibugyo #ebolavirus #outbreak in #DRC and #Uganda: rapid #assessment from the #ESCMID Emerging Infections Subcommittee, https://etidiohnew.blogspot.com/2026/06/bundibugyo-ebolavirus-outbreak-in-drc.html

#US taps small #SanDiego #biotech for experimental #Ebola treatment as epidemic worsens
Biotech, #MappBiopharmaceutical, “has shipped doses for potential use in high-risk individuals,” a spokesperson for HHS said, “as part of coordinated preparedness efforts.”
The antibody was originally developed in collaboration with the B-ARPA for Sudan virus, a species of #ebolavirus separate from the #Bundibugyo species that is causing the current epidemic.
https://www.fiercebiotech.com/biotech/us-taps-small-san-diego-biotech-experimental-ebola-treatment-epidemic-worsens
https://archive.ph/JXeDb

> At least 80 deaths have now been reported in a new Ebola outbreak in eastern Congo as health officials race to contain the spread through screening and contact tracing efforts. Authorities say the outbreak involves the Bundibugyo strain of Ebola and has already spread across multiple health zones in Ituri province, with a related case also confirmed in neighboring Uganda. Local residents described constant burials and growing fear as officials warned the region’s instability and limited infrastructure could complicate containment efforts. The World Health Organization and regional health agencies are assisting Congo as concerns grow about wider cross-border transmission.

-- Aaron Parnas

https://open.substack.com/pub/aaronparnas/p/news-trump-to-control-truth-commission

#WHO #congo #ebolavirus
#uganda #africa #healthNews
#bundibugyo #outbreakalert